|
NSMCE2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.194800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.951000E-01 |
| Normal-vs-Stage2 |
4.102200E-01 |
| Normal-vs-Stage3 |
5.698400E-01 |
| Normal-vs-Stage4 |
1.799030E-01 |
| Stage1-vs-Stage2 |
2.409000E-01 |
| Stage1-vs-Stage3 |
7.787600E-01 |
| Stage1-vs-Stage4 |
2.334200E-01 |
| Stage2-vs-Stage3 |
2.121600E-01 |
| Stage2-vs-Stage4 |
7.164000E-02 |
| Stage3-vs-Stage4 |
3.770000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.936800E-01 |
| Normal-vs-AfricanAmerican |
4.854200E-01 |
| Normal-vs-Asian |
6.773800E-01 |
| Caucasian-vs-AfricanAmerican |
7.044600E-01 |
| Caucasian-vs-Asian |
8.454200E-01 |
| AfricanAmerican-vs-Asian |
8.414800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.664800E-01 |
| Normal-vs-Female |
6.453600E-01 |
| Male-vs-Female |
9.327400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.492200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.829200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.065000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.893400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.929800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.671800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.976000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.006800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.274400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.685800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.513900E-02 |
| Classical-VS-Follicular |
2.908600E-01 |
| Classical-VS-Other |
8.502600E-01 |
| Classical-VS-Normal |
5.453000E-01 |
| Tall-VS-Follicular |
3.199500E-02 |
| Tall-VS-Other |
4.948000E-01 |
| Tall-VS-Normal |
5.173700E-02 |
| Follicular-VS-Other |
6.407800E-01 |
| Follicular-VS-Normal |
5.875200E-01 |
| Other-VS-Normal |
6.261400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.172000E-01 |
| Normal-vs-N1 |
2.490000E-01 |
| N0-vs-N1 |
1.038210E-01 |
|
|
